Jazz Pharmaceuticals plc 4

Non-employee director Laura Hamill received an award of 1,605 restricted stock units of Jazz Pharmaceuticals plc ordinary shares.

On August 5, 2026, Laura Hamill, a non-employee director of Jazz Pharmaceuticals plc, received an award of 1,605 restricted stock units representing ordinary shares under the company’s 2007 Amended and Restated Non-Employee Directors Stock Award Plan, at a grant price deemed to be $0.0 for Form 4 reporting purposes. The RSUs will vest in full on July 23, 2027, subject to her continued service and other conditions. Following this award, her direct holdings increased to 8,538 ordinary shares (including the newly awarded units), though the Form 4 does not provide a market price from which to calculate the dollar value of the grant or her post-transaction holdings.

Filing Facts

CIK

1232524

Ticker

JAZZ

Form

4

Source Type

fda

Accession

0001751804-26-000002

Alert Tier

5